Cargando…

Cognitive Function in Primary Sjögren’s Syndrome: A Systematic Review

Background: Cognitive disorders are reported to be common in patients with primary Sjogren’s syndrome (pSS). In some cases, they are the first clinical manifestation, preceding the diagnosis of pSS by two years on average. Aim: A systematic review was conducted to explore cognitive impairment in pSS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzo, Ciro, Martinez-Suarez, Eva, Kechida, Melek, Isetta, Marco, Serra-Mestres, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523842/ https://www.ncbi.nlm.nih.gov/pubmed/30991679 http://dx.doi.org/10.3390/brainsci9040085

Ejemplares similares

Is primary Sjögren’s syndrome a risk factor for malignancies different from lymphomas? What does the literature highlight about it?
por: Manzo, Ciro, et al.
Publicado: (2017)

Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with Glucocorticoids
por: Manzo, Ciro, et al.
Publicado: (2018)

Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
por: Manzo, Ciro, et al.
Publicado: (2021)

The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios
por: Manzo, Ciro, et al.
Publicado: (2022)

Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Periodontitis and rheumatoid arthritis: three messages from published literature to clinical practice
por: Manzo, Ciro, et al.
Publicado: (2020)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
por: Manzo, Ciro, et al.
Publicado: (2022)

Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome
por: Manzo, Ciro, et al.
Publicado: (2019)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023)

Pathological changes of renal biopsy in Sjögren Syndrome
por: Sablón-González, Nery, et al.
Publicado: (2018)

Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review
por: Wisidagama, Sharadha, et al.
Publicado: (2021)

Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center Study
por: Manzo, Ciro, et al.
Publicado: (2023)

Catatonia in older adults: A systematic review
por: Jaimes-Albornoz, Walter, et al.
Publicado: (2022)

Labial salivary gland biopsy and secondary Sjögren’s syndrome: where we are and where we want to be
por: Manzo, Ciro
Publicado: (2019)

Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case
por: Manzo, Ciro
Publicado: (2019)

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome
por: Blanc, Frederic, et al.
Publicado: (2013)

Clinical presentation, radiological findings and treatment options in Hughes-Stovin syndrome
por: Kechida, Melek, et al.
Publicado: (2022)

Neuroprotective modulation of the unfolded protein response in Marinesco-Sjögren syndrome: PERK signaling inhibition and beyond
por: Restelli, Elena, et al.
Publicado: (2019)

Multiple paraneoplastic syndromes revealing non-small cell lung carcinoma
por: Youssef, Monia, et al.
Publicado: (2014)

Marginal Zone B (MZB) Cells: Comparison of the Initial Identification of Immune Activity Leading to Dacryoadenitis and Sialadenitis in Experimental Sjögren’s Syndrome
por: Peck, Ammon B., et al.
Publicado: (2023)

Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations
por: Koçer, Belgin, et al.
Publicado: (2016)

Nephrocalcinosis in primary Sjögren's syndrome
por: Gharbi, Chems, et al.
Publicado: (2014)

Biomarkers for Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2015)

Imaging in Primary Sjögren’s Syndrome
por: van Ginkel, Martha S., et al.
Publicado: (2020)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Montreal cognitive assessment in primary sjogren’s syndrome: A brief screening tool
por: Kurtuluş, Fatma, et al.
Publicado: (2019)

The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients
por: Goulabchand, Radjiv, et al.
Publicado: (2022)

Shrinking Lung Syndrome in Primary Sjögren Syndrome
por: Uslu, Sadettin, et al.
Publicado: (2020)

Neurological Disorders in Primary Sjögren's Syndrome
por: Tobón, Gabriel J., et al.
Publicado: (2012)

Primary Sjogrens Syndrome in a Child
por: Kumar, K. Jagadish, et al.
Publicado: (2015)

Recent advances in primary Sjogren's syndrome
por: Holdgate, Nicholas, et al.
Publicado: (2016)

Pleuritis associated with primary Sjogren syndrome
por: Hosoda, Chiaki, et al.
Publicado: (2017)

Neurological manifestations of primary Sjögren’s syndrome
por: Perzyńska-Mazan, Joanna, et al.
Publicado: (2018)

Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome
por: Alunno, Alessia, et al.
Publicado: (2018)

Mycophenolate for the Treatment of Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2020)

Ophthalmologic Manifestations of Primary Sjögren’s Syndrome
por: Roszkowska, Anna Maria, et al.
Publicado: (2021)

Renal Disease in Primary Sjögren’s Syndrome
por: Aiyegbusi, Oshorenua, et al.
Publicado: (2020)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hrkitqmtqkmqsgk3b59qkop234